FDA adds microbiological assessments to ophthalmic drug quality guidance
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)ComplianceOTCPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyUnited States